Publications
Print PDF
Second Amgen Biosimilar Decision Provides More Clarity
July 6, 2016
John Aquino
Bloomberg BNA

Axinn counsel Stacie Ropka was quoted in the Bloomberg BNA article, "Second Amgen Biosimilar Decision Provides More Clarity."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.